Sionna Therapeutics, Inc.
SION
$6.46
-$0.08-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.28% | 25.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.70% | 25.36% | |||
| Operating Income | -9.70% | -25.36% | |||
| Income Before Tax | -11.60% | -31.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.60% | -31.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.60% | -31.01% | |||
| EBIT | -9.70% | -25.36% | |||
| EBITDA | -9.75% | -25.51% | |||
| EPS Basic | -11.04% | -30.18% | |||
| Normalized Basic EPS | -11.03% | -30.19% | |||
| EPS Diluted | -11.04% | -30.18% | |||
| Normalized Diluted EPS | -11.03% | -30.19% | |||
| Average Basic Shares Outstanding | 0.51% | 0.64% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||